However, increased SPINK1 secretion was reported to be related to vemurafenib resistance in BRAF V600E-mutant colorectal cancers, indicating the need to target different gene variant subtypes of HCC during chemotherapy (29193645). This evidence concerns the gene SPINK1 and colorectal cancer.